2. Categories

      eCliniqua: eClinical Products, Electronic Data Capture (EDC), Market Insights, Regulatory Issues & Drug Safety, Trial Design and Logistics

  3. ECLINIQUA IS SPONSORED BY:

    medidata-logo.gif Cmed-Technology.jpg
    Oracle_Healthsciences.jpg





  5. Clinical IT Products

    Cmed Technology Releases Timaeus 5 On-Demand eClinical Platform Cmed Technology

    Pegasystems Releases Customer Process Manager For Life Sciences

    Medidata announces Insights, the latest version of its clinical business analytics solution

    Medidata announces streamline enterprise coding solution

    BioClinica Releases Onpoint CTMS to Meet Growing Market Demand

    ClearTrial releases v4.2 with API

    Cmed announces forthcoming Timaeus Guided Trial Builder product

  6. FOLLOW US ON:

    /><map name=

  7. CROs IN THE NEWS

    (12 articles) Quintiles

    (10 articles) Parexel International

    (8 articles) Perceptive Informatics

  8. BIOTECHNOLOGY COMPANIES IN THE NEWS

    (8 articles) Amylin Pharmaceuticals

    (6 articles) Exelixis

    (6 articles) Vertex Pharmaceuticals

    (5 articles) Human Genome Sciences

    (5 articles) Genentech

  9. BIOPHARMA COMPANIES IN THE NEWS

    (35 articles) Merck & Co Inc

    (29 articles) Pfizer Inc

    (28 articles) Eli Lilly and Company

    (24 articles) sanofi-aventis

    (22 articles) Johnson & Johnson

  • Sponsored Links

    Optimize Trial Design through Simulation Modeling - Webinar

    White Paper: Improving Drug Manufacturing Quality with a SDMS

    Exemplar Biomarker Discovery – Your Complete Solution for Personalized Medicine

    Free Webinar - Running Adaptive Clinical Trials: Myth and Reality

    Free Webinar on Compliance and Patient Data –Meeting the Needs!

    Grid Engine @ Univa: 200 improvements and counting

    Analyze, compare & visualize NGS datasets with CLC bio's intuitive platform

    Protect Your Kingdom - RSA Conf 2012

    Free whitepaper: Understanding Legal Issues Surrounding Electronic Lab Notebook Records

    ClearTrial Named a Gartner "Cool Vendor in Life Sciences, 2011"

    Data Repository, ELN, & Laboratory Execution - Waters® NuGenesis® SDMS

    Discover Timaeus 5, an on-demand eClinical platform for Study Design Through Reporting.

    Free WhitePaper: Increase Innovation with Improved Scientific Data Management

    Biotech 2010 Life Sciences: Adapting for Success

    Online community for pioneers in next-gen sequencing & bioinformatics

    Barnett International: Training Strategy and Consulting

    Competitive Analysis & Insight with Concise Research Reports

    Current & Innovative NGS Technologies, Services & Markets

    Next Generation Mass Spectrometry

    New Trends in Preventive and Therapeutic Vaccines

    Next-Generation Sequencing Technologies: Applications and Markets

  • Life Science Jobs

    1. CLINICAL NEWS & ANALYSIS

      1. Remedies for Safer Drugs

        Explore Bio-IT World (Jan 21 2012) Regulatory Issues & Drug Safety

        Pharmacovigilance experts have an abundance of signal detection tools to sift through large quantities of data seeking causal relationships between adverse events (AEs) and experimental drugs. They also have an assortment of data mining tools capable of finding statistical associations suggestive of problems regarding approved drugs. All this technology is intended to safeguard clinical trial participants, patients, and the reputation of recall-weary drug developers. But drug safety specialists can’t be sure which technology or signal detection method is best. (Read Full Article)

        Comment

      2. 19 Clinical Trials Aren't Enough

        Explore Fool.com (Jan 20 2012) Electronic Data Capture (EDC) , Trial Design and Logistics

        The FDA rejects Bristol-Myers and AstraZeneca's dapagliflozin. (Read Full Article)

        Comment Mentions:   FDA   AstraZeneca   The Food and Drug Administration

      3. Medidata: Integrating Infrastructure for Clinical Trials

        Explore Bio-IT World (Jan 18 2012) Electronic Data Capture (EDC) , Regulatory Issues & Drug Safety , Trial Design and Logistics

        Bio-IT World | Glen de Vries thought he would be teaching biology or chemistry in college, but somewhere en route to a satisfying career in academic research, he got distracted. Bio•IT World chief editor Kevin Davies spoke to de Vries about the progress of Medidata and the state of e-clinical technology in general. (Read Full Article)

        Comment Mentions:   SAP   Kevin Davies, Ph.D.   Medidata

      4. Biodesix Receives New EU and US Patents for Blood-based Oncology Tests

        Explore businesswire.com (Jan 9 2012) Market Insights

        Biodesix has announced the issuance of three additional patents which provide intellectual property protection for head and neck tests, lung cancer patient selection, and monitoring. (Read Full Article)

        Comment Mentions:   Biodesix

      5. FDA Has (Some) Social Media Advice For Pharma

        Explore WSJ Blogs (Jan 9 2012) Regulatory Issues & Drug Safety , Trial Design and Logistics

        Last month, the FDA released draft guidance on "responding to unsolicited requests for off-label information about prescription drugs and medical devices." (Read Full Article)

        Comment Mentions:   FDA

      6. See all articles >>

    2. ELSEWHERE IN THE PRESS

      1. Knome’s New CEO Signals New Directions in Genome Interpretation

        Explore Bio-IT World (Jan 9 2012) Trial Design and Logistics

        Bio-IT World | Knome, the first company to offer direct-to-consumer genome analysis, has appointed neurologist and biotech executive Martin Tolar as its new CEO as it seeks to push further into two prime markets for genome interpretation software -- biopharma and clinical genomics. (Read Full Article)

        Comment Mentions:   Harvard Medical School   Pfizer Inc   Beckman Coulter

      2. FDA Releases Social Media Guidelines

        Explore Bio-IT World (Jan 9 2012) Regulatory Issues & Drug Safety

        News Brief | The Food and Drug Administration has released its guidelines for how pharma companies use social media to respond to questions about off-label use of drugs and devices. But they're still not as comprehensive as many hoped for. (Read Full Article)

        Comment Mentions:   FDA   The Food and Drug Administration

      3. Bristol-Myers buying Inhibitex for $2.5 billion

        Explore MarketWatch (Jan 8 2012) Trial Design and Logistics

        Bristol-Myers Squibb purchasing Inhibitex, a specialist in hepatitis C treatments, for $2.5 billion (Read Full Article)

        Comment Mentions:   Bristol-Myers Squibb   Bristol-Myers

      4. Quintiles consolidates patient communities into new Digital Patient unit

        Explore pmlive.com (Jan 6 2012) Trial Design and Logistics

        Contract research organisation Quintiles has combined its digital patient resources, including two online patient communities, into a single unit. The company’s new Digital Patient unit will bring together MediGuard.org and ClinicalResearch.com to offer its pharma clients a more efficient patient recruitment service. (Read Full Article)

        Comment Mentions:   Microsoft Corp   Google Inc   Quintiles

      5. Lilly projects sharp drop in 2012 profit

        Explore reuters.com (Jan 5 2012) Trial Design and Logistics

        (Reuters) - Eli Lilly & Co forecast a sharp plunge in profits for 2012, the first full year its top-selling Zyprexa schizophrenia treatment faces generic competition, and its shares fell as much as 3.6 percent. (Read Full Article)

        Comment Mentions:   Thomson Reuters   Pfizer Inc   Eli Lilly and Company

      6. See all articles >>

    3. ELSEWHERE IN THE PRESS

      1. Expect Measurable ROI of Innovation in 2012

        Explore Bio-IT World (Jan 5 2012) Trial Design and Logistics

        In 2011, biopharma sponsors continued to rely on an increasing number of contract research organizations (CROs) and eClinical technology solutions to support the research of drugs and related devices. Biopharma sponsors’ most precious asset: controlled access to clinical data throughout the course of trials, became more crucial and challenging than ever. Setting the stage for 2012, CROs are now not only responsible for executing studies and helping analyze and evaluate clinical data, but also offering access to data from all trials in one location. (Read Full Article)

        Comment

      2. Flurry Of Cancer Pacts

        Explore Chemical & Engineering News (Jan 3 2012) Market Insights

        The year 2011 ended with multiple acquisitions and research partnerships through which the drug majors Takeda Pharmaceutical, Merck & Co., Eli Lilly & Co., and AstraZeneca gain access to compounds that biotech firms are developing for the treatment of cancer. (Read Full Article)

        Comment Mentions:   AstraZeneca   Merck & Co.   Eli Lilly & Co.

      3. New year, new science

        Explore Nature Publishing Group (Jan 2 2012) Trial Design and Logistics

        New year, new science Nature looks ahead to the key findings and events that may emerge in 2012. (Read Full Article)

        Comment Mentions:   US National Institutes of Health   FDA   NASA

      4. Perceptive Informatics DataLabs EDC Solution Implemented by 15 of the top Global Biopharmaceutical Companies

        Explore Industry (Dec 30 2011) Electronic Data Capture (EDC)

        News Brief | This latest milestone was preceded by an independent report from Industry Standard Research, which ranked the DataLabs EDC solution the highest in overall satisfaction among EDC solutions in a survey of principal investigators and site coordinators. (Read Full Article)

        Comment Mentions:   Parexel International   Perceptive Informatics   PAREXEL International PAREXEL International Corporation

      5. The Perfect Pair: Drugs and Companion Diagnostics

        Explore Bio-IT World (Dec 29 2011) Regulatory Issues & Drug Safety

        New York Times | More and more often, the FDA is requiring personalized drugs to have companion diagnostic tests associated with them before approval. The trend has prompted some awkward partnerships in drug discovery. (Read Full Article)

        Comment Mentions:   FDA

      6. See all articles >>